Selank

What It Is

A synthetic heptapeptide developed at the Russian Academy of Medical Sciences as an analog of the endogenous immunomodulatory peptide tuftsin, with an added stabilizing C-terminal tripeptide. Studied for its effects on GABAergic and serotonergic signaling in preclinical anxiety models.

How It Works

Selank enters the research model intranasally or systemically

→

Crosses the blood-brain barrier

→

Modulates GABAergic and serotonergic systems

→

Anxiety-related and cognitive pathways are studied

What Researchers Study It For

GABA-system modulation studies

Anxiety-pathway preclinical models

BDNF expression investigations

Immunomodulatory neuropeptide research

Common Research Protocols

In published research, Selank is most commonly administered intranasally in microgram-per-kg doses, with peer-reviewed studies emphasizing rapid CNS uptake via the nasal route.

Community Interest Areas

The neuropeptide research community continues to study Selank because — unlike classical benzodiazepine GABA modulators — it appears to influence anxiety-related circuits without producing the same sedation or dependency profiles in animal studies. Investigators have probed its effects on enkephalinase activity, BDNF expression, and stress-behavior endpoints.

Tuftsin Analog Synthetic stabilized heptapeptide derived from tuftsin

Intranasal Peer-reviewed research emphasizes nasal-route CNS uptake

For research purposes only. Not intended for consumption, clinical application, or diagnostic use.

What It Is

How It Works

What Researchers Study It For

Common Research Protocols

Community Interest Areas

What Are Peptides?

Are Peptides Safe?